Oncology

21 Sep 2017

4123
(553 votes)

Rigvir® for Sale: How It Works and How You Can Get Qualified for Virotherapy Within Three Days

Cancer is insidious. It can escape after a full course of chemo or radio and then show up again. This is what makes most patients search for treatment alternatives to be used in addition to conventional medicine or independently.

And Rigvir® is one of these options for you to consider. It is the first non-genetically modified oncolytic virus able to recognize healthy and cancer-affected cells and kill the malicious disease without doing harm to surrounding tissues.

Discovered In the 1960s, Registered At The Beginning Of XXI Century In 3 Countries, Rigvir® Sale Is Not Limited To Those Countries

The medication was discovered back in 1960–70s by the team of a scientist and immunologist Aina Muceniece. The virus was stemmed from the digestive kid system and passed a series of clinical trials (in 1968) to prove its significant therapeutic power. The medication was patented in 2002, registered in 2004 by the state authorities of Latvia as the major melanoma treatment. In 2015 and 2016 two more countries recognized Rigvir® as a working medication.

rigvir sale

Rigvir® is stored in vials for future injections

However, it does not mean that Rigvir® is accessible to the patients only in those countries. Indeed, over the last 15 years more than 3,000 patients preferred visiting a German clinic in Brannenburg to get Rigvir® treatment, as well as to enhance it with a range of other therapies: detox, acupuncture, Buserelin therapy, local hyperthermia and minimally-invasive surgery. All of them will be discussed in detail later in the article.

How Exactly Rigvir® Works: From Intramuscular Injection To Scanning And Killing Malignancies

One of the widespread questions about Rigvir® is that of how it works. As said before, the virus occurs naturally and has oncotropic and oncolytic effects. That is to say, Rigvir® identifies cancer cells in a human body and then replicates inside them destroying the tumor from within.


Rigvir® stimulates immune system to resist cancer and causes no harm to healthy tissues. The medication does not reproduce itself with time. Neither does it lead to addictiveness, so it’s totally safe for your organism.

The only side-effects noted so far include slightly feverish temperature (up to 99.5°F/37.5°C) and fatigue during the first three days of the treatment.

What Diagnoses Rigvir® is Capable of Handling? Melanoma and Solid Tumours, Expect For Myeloma, Leukemia and Lymphoma

Rigvir® is primarily prescribed to melanoma patients and, as it turned out, the drug proves effective in other limited number of cases. It was discovered that these types of cancer are also vulnerable to Rigvir®:

  • Bladder cancer

  • Prostate cancer

  • Brain cancer

  • Breast cancer

  • Lung cancer

  • Kidney cancer

  • Stomach cancer

  • Ovarian cancer

  • Anal cancer

  • Cervical cancer etc.

Survival Rates for Cancer Patients After Rigvir® Therapy Prove That The Treatment Increases Chances To Survive

This is what we know about success rates of the Rigvir® therapy (as stated by Acta Medica Lituanica, a medical journal, in 2002):

  • Melanoma patients treated with surgery had a 3-year survival rate in 46–58% of cases. The Rigvir® patients showed the same survival rate (3 years) in 57–84% of cases while 44–66% of patients had a 5-year survival rate.

  • Ocular melanoma patients treated with Rigvir® had a 3-year survival rate in 90% of cases and a 5-year survival rate in 70% of cases.

  • Patients with stage III stomach cancer had a 5-year survival rate after surgery only in 24–33% of cases. Whereas the patients who passed through a virotherapy complete course had the same survival rate in 47–60% of cases.

  • 41–68% of patients with stage II-IV rectal cancer had a 5-year survival rate after surgery, while the patients treated with Rigvir® (having the same diagnosis) showed a 5-year survival rate in 71–78% of cases.  

Before applying Rigvir®, you should consider the following requirements to become a successful candidate for Rigvir® treatment.

  1. You must be 18+ years old because the existing clinical experience in virotherapy for cancer is related to adults only.

  2. Your must have a confirmed oncological diagnosis because Rigvir® vaccine cannot be used as a preventative measure.

  3. You must have a solid tumor because there’s no clinical experience showing that Rigvir® can help fight liquid cancers such as lymphoma, myeloma, or leukemia.

You Can Have Rigvir® Injections After Your Case Is Examined By The German Medical Board Within Three Days

As we’ve mentioned before, the clinic in Germany provides Rigvir® to overseas patients. Of course, it’s risky to fly there without knowing that Rigvir® can help you. To evaluate whether virotherapy can be applied in your case, the medical team from the clinic has to see your documents. They include:

  • Biopsy (or pathology) report
  • Cytology report
  • Complete blood test with white blood cells indicated (no older than 2 weeks)
  • Radiology reports
  • Blood biochemistry, including alanine aminotransferase, creatinine etc.

Upload these files in .jpg/.pdf/.docx to WeTransfer service and send us via clicking the button below. The evaluation is free and takes up to 2–3 working days. As soon as the oncologists assess your case, our manager will contact you to notify on the results.

We understand that the information you provide is strictly confidential. It will be seen only by doctors and no third parties.

If you’ve got positive answer regarding the therapy in Germany, you can start booking your flight tickets to Munich International Airport. If the assessment of your case shows you can't benefit from virotherapy, you’ll be informed immediately.

One-Week Stay in Germany: Rigvir® Sale, Accommodation, Transfer And All Other Details You With To Know

If the cancer specialists conclude you can benefit from virotherapy based on the medical files you provide, together with the medical statement you will receive details of the treatment package that best suits your health needs. Basically, it includes:

  • Meet and greet at Munich International Airport, comfortable transfer to the clinic (it takes near 1,5 hour)

  • Tests to check the absence of allergical response to Rigvir®

  • Rigvir® injections

  • Organic and healthy food, based on diet recommendations given by a local nutritionist

  • Daily consultations with cancer specialists

  • 24/7 support by a medical and administrative team who speak English

  • Accommodation for dwelling alone or with your accompanying person (in the second case, additional fee has to be paid)

Additionally, after a consultation with doctors, you may have:

Detox — the process of cleaning the body from the toxins by eating healthy food and being physically active.

Acupunсture therapy — activating the immune system by inserting a number of needles into your body under the specialist control.

Buserelin treatment — therapy that helps to regulate reproductive hormones and suits well to help prostate and breast cancer patients to recover.

Minimally-invasive surgery, also called gentle is applied to patients with solid tumours, but it performed with minimal number of cuts to speed up the recovery.

Local hyperthermia was also designed for prostate cancer patients. By using heat under special medical conditions, it can make malignant cells destroy themselves.

 

Rigvir sale Rigvir sale Rigvir saleRigvir saleRigvir saleRigvir sale
 
 

The cost of the 7-day program in Germany is near 6,000 EUR (6,670 USD). To get more precise calculations, please provide your medical files for evaluation via the red button. In case you have any questions, you can also pose them via the red button. We’ll get back to you within 24 hours but usually sooner.